https://www.captis.com/wp-content/uploads/2021/02/PBR-1-2.jpg8001280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-25 02:22:222021-02-25 02:57:12ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults
https://www.captis.com/wp-content/uploads/2021/02/PBR-2-2.jpg8531280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-24 08:02:052021-02-24 08:57:41UCB expands partnership with Microsoft to speed up drug development
https://www.captis.com/wp-content/uploads/2021/02/PBR-3.jpg9601280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-23 00:43:282021-02-23 00:58:02AstraZeneca withdraws Imfinzi indication in US for bladder cancer
https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png00CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-19 02:50:392021-02-19 02:50:39USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment
https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png00CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-18 08:50:332021-02-18 08:50:34GlaxoSmithKline and Vir Biotechnology to expand Covid-19 partnership
https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png00CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-18 01:53:572021-02-18 01:53:58Pfizer, BioNTech to supply 200 million more Covid-19 vaccine doses to Europe